Brevan Howard Capital Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Sell
7,202
-1,452
-17% -$58.5K ﹤0.01% 1713
2026
Q1
$289K Buy
+8,654
New +$362K ﹤0.01% 1649
2025
Q4
– Sell
-12,195
Closed -$371K – 2153
2025
Q3
$371K Buy
12,195
+3,501
+40% +$108K ﹤0.01% 1439
2025
Q2
$256K Sell
8,694
-314
-3% -$9.39K ﹤0.01% 1610
2025
Q1
$315K Buy
+9,008
New +$357K ﹤0.01% 852
2024
Q2
– Sell
-9,915
Closed -$290K – 1315
2024
Q1
$290K Buy
+9,915
New +$301K ﹤0.01% 672

Other funds holding OMCL

Brevan Howard Capital Management's OMCL Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Omnicell (OMCL) stake by 17% in Q2 2026, selling an estimated $58.5K and leaving 7,202 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Brevan Howard Capital Management first reported a position in OMCL in Q1 2024 and has held it in 6 quarters since. The position peaked at $371K in Q3 2025. 307 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Brevan Howard Capital Management held 7,202 shares of Omnicell worth $299K as of Q2 2026.
  • Brevan Howard Capital Management sold 1,452 Omnicell shares in Q2 2026, an estimated $58.5K.
  • Omnicell made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1713 holding.
  • Brevan Howard Capital Management first reported a position in Omnicell in Q1 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Omnicell position peaked at $371K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.